Navigation Links
Novel Treatment Found To Prolong Survival Of Liver Cancer Patients

Surgery remains the most effective treatment option for patients with liver cancer. A cloud of confusion however remains regarding the best way to treat a patient who harbors a liver tumor that cannot be removed by surgery. //Infact very little surgical options are currently available for this group of patients.

Thanks to the perseverant work of the researchers who have now suggested a novel plan for combating these tumors using radiotherapy. The radiotherapy is targeted precisely at the tumor and is delivered in combination with chemotherapy approximated to a dose of 400 folds the conventional dose. The radiation oncologists designed a treatment that directly targets the tumor, using conformal radiation techniques that pinpoint precisely where the radiation beams go. This unique approach minimizes the radiation exposure to normal liver tissue.

The study was conducted on nearly 128 patients with either cancer of the bile duct, liver or colon that were regarded as inoperable. The study participants received radiation twice daily for two weeks, along with a continuous infusion of the chemotherapy drug floxuridine. The chemotherapy was administered through a catheter into the artery that supplies the liver. A two-week break was allowed before the same regime was continued for another two weeks.

Liver cancers have limited success with radiotherapy owing to the fact that the liver is extremely sensitive to radiation. In addition, multi-drug resistance is a common problem manifested in a majority of the liver cancers. Therefore has not been regarded as a viable option in the treatment strategy.

The study participants had a projected survival rate of eight or nine months. The treatment was found to prolong the survival rate to as much as 15.8 months in a statistically significant way in comparison to the traditional rates. Patients with liver, bile duct and colon cancer were found to live for an average of 15.2, 13.2 and 17.2 months respectively.

Nearly, one third of the treated patients had severe complications ranging from upper gastrointestinal ulcers or bleeding, liver disease to problems associated with the catheter. Research is also underway to further refine techniques for effective delivery of radiation. It has also been proposed to test liver function as a parallel approach to predict the response of the patients to the combined modality approach.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2017)... ... 2017 , ... "At your fingertips" electronic access to patient ... Delaware Health Information Network (DHIN) have partnered to improve connectivity of this data ... exchange, DHIN stores and shares real-time health data for more than 2 million ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a ... Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly credentialed ... roof. Smiles by Seese serves patients of all ages with excellence in general, restorative, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 2017 Provides understanding and access to ... into by the worlds leading healthcare companies. ... Description The Global Renal Failure Partnering Terms and ... to partnering deals and agreements entered into by ... Trends in partnering deals - Top deals ...
(Date:2/20/2017)... 20, 2017 The report analyzes the worldwide markets for Drug-Eluting ... the US, Canada , Japan ... Latin America , and Rest of World. ... ... provided for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... Feb. 20, 2017 This report analyzes the worldwide ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , and Rest ... http://www.reportlinker.com/p04707131-summary/view-report.html Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Medicine Technology: